Drug Topics E-News:
Having trouble viewing this e-mail? Click here. 		You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
Modern Medicine Network
Resource Centers
CME/CE
Medical Economics
Careers
Community
Clinical Tools
  Drug Topics E-News
 
AUGUST 25 , 2009
IN THIS ISSUE
• FDA unveils rules
• Alaska gets Walgreens
• NCPA starts new program
• FDA approves Saphris
  TOP SEARCHES: CE // Diabetes // Vertex

FDA issues rules for investigational drugs
The U.S. Food and Drug Administration (FDA) published two rules recently to help clarify how very ill patients can get access to investigational drugs and biologics when they are not eligible to participate in a clinical trial and do not have other satisfactory treatment options. More...

Alaska gets its first Walgreens
Walgreens has opened its first store in Alaska, giving the chain a presence in all 50 states. The new Walgreens store, opened in Wasilla, Alaska, will be the only 24-hour pharmacy in the state, according to a statement from the company. More...

NCPA launches student ambassador program
The National Community Pharmacists Association (NCPA) has launched its Student Ambassador Program, which recruits independent community pharmacy owners to visit pharmacy students to discuss the benefits of business ownership and offer advice on how to navigate the process. More...

FDA approves Saphris to treat schizophrenia and bipolar I
The U.S. Food and Drug Administration has approved Saphris tablets to treat adults with schizophrenia and bipolar I disorder in adults. More...


Key Topic Updates
Issues & Trends
 
Professional
 
Clinical
 
Technology
 
Regulatory & Law

Key Topic Updates

Survey
Is direct-to-consumer advertising a good idea?
Yes   10%
No   90%

This month we would like to know...

How often do you implement therapeutic substitution?

<20% of prescriptions 21 to 50% of prescriptions 51 to 75% of prescriptions >75% of prescriptions

Click here to vote

Contact Us
Click here to learn more about the Drug Topics editorial team.

Click here to contact the Drug Topics editorial team.

Click here to contact the Drug Topics sales team.

Click here to learn about direct mail, reprints and classifieds in Drug Topics.

Drug Topics Digital Edition
Click here to to view the most recent issue.

Click here to subscribe.

Follow us on Twitter.

Share Drug Topics E-News with a friend

You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.